Novel biomarkers for diabetic kidney disease
Although diabetic kidney disease (DKD) remains one of the leading causes of reduced lifespan in patients with diabetes mellitus; its prevalence has failed to decline over the past 30 years. To identify those at high risk of developing DKD and disease progression at an early stage, extensive research...
Saved in:
Main Authors: | Chan-Young Jung (Author), Tae-Hyun Yoo (Author) |
---|---|
Format: | Book |
Published: |
The Korean Society of Nephrology,
2022-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Urine myo-inositol as a novel prognostic biomarker for diabetic kidney disease: a targeted metabolomics study using nuclear magnetic resonance
by: Soie Kwon, et al.
Published: (2023) -
Diabetic kidney disease: An overview of prevalence, risk factors, and biomarkers
by: Salman Hussain, et al.
Published: (2021) -
Extracellular vesicles in kidneys and their clinical potential in renal diseases
by: Sul A Lee, et al.
Published: (2021) -
High muscle‐to‐fat ratio is associated with lower risk of chronic kidney disease development
by: Jong Hyun Jhee, et al.
Published: (2020) -
Predictive performance of the new race-free Chronic Kidney Disease Epidemiology Collaboration equations for kidney outcome in Korean patients with chronic kidney disease
by: Hyoungnae Kim, et al.
Published: (2023)